Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The study was performed before formal guidelines but according to best practice at that time, and according to GLP .

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
The study was perfermed before any formal guidelines but according to best practice at that time.

GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Reference substance name:
Active enzyme protein of Lipase, triacylglycerol (EC no. 232-619-9, CAS no. 9001-62-1, EC name: Lipase, triacylglycerol, Enzyme Class No.: 3.1.1.3)
Cas Number:
9001-62-1
Molecular formula:
Not applicable, see remarks
IUPAC Name:
Active enzyme protein of Lipase, triacylglycerol (EC no. 232-619-9, CAS no. 9001-62-1, EC name: Lipase, triacylglycerol, Enzyme Class No.: 3.1.1.3)
Constituent 2
Reference substance name:
Protein as a constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available
IUPAC Name:
Protein as a constituent of enzyme deriving from the fermentation or extraction process
Constituent 3
Reference substance name:
Inorganic salts as a constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Inorganic salts as a constituent of enzyme deriving from the fermentation or extraction process
Constituent 4
Reference substance name:
Carbohydrates constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Carbohydrates constituent of enzyme deriving from the fermentation or extraction process
Constituent 5
Reference substance name:
Lipids as a constituent of enzyme deriving from the fermentation or extraction process
Molecular formula:
Not available. See remarks.
IUPAC Name:
Lipids as a constituent of enzyme deriving from the fermentation or extraction process
Test material form:
solid: particulate/powder
Remarks:
powder
Details on test material:
- Lot/batch No.: PPW 1798
- Expiration date of the lot/batch: December 1996

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River (UK) Limited, Manston, Kent, UK.
- Age at study initiation: 8-9 weeks
- Weight at study initiation: 162-219 g
- Housing: 2 per cage.
- Diet (e.g. ad libitum): Rat and Mouse Breeder Diet No. 3 SQC Expanded (ground) ad libitum
- Water : domestic water ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20°C ± 2°C
- Humidity (%): 55% ± 10%
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: feed
Vehicle:
other: Diet without test substance
Details on exposure:
DIET PREPARATION
- Rate of preparation of diet: Fresh diet batches were prepared weekly during the study, each dose level being prepared independently.
- Mixing appropriate amounts of lipase with the rat diet to following dose levels, 0, 2, 5 and 10 % in the diet.
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Samples were removed from each mixed batch of diet and despatched to the Sponsor for analysis of enzyme activity in lipase units/g.
Details on mating procedure:
108 female rats arrived timed-mated on day 1 of gestation at the research lab.
Duration of treatment / exposure:
12 days (day 6 - day 17 of gestation).
Frequency of treatment:
The diet contained a constant concentration of test material and was available ad libitum.
Duration of test:
The animals had access to treated diet from day 6 - day 17 of gestation (day 0 = day of verification of copulatory plug in situ).
No. of animals per sex per dose:
27 mated females
Control animals:
yes, plain diet

Examinations

Maternal examinations:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: During each day

BODY WEIGHT: Yes, at day 1, 6, 9, 13, 17 and 20 of gestation

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each cage determined daily
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No
Ovaries and uterine content:
On day 20, the animals were killed by nitrogen asphyxiation. The reproductive tract was dissected out, weighed and then examined.
Fetal examinations:
- External examinations: Yes all per litter
- Soft tissue examinations: Yes, 1/3 of the foetuses by free-hand sectioning (Wilson), while the other 2/3 were fixed for gross visceral abnormalities.
- Skeletal examinations: Yes, 2/3 of the foetuses
- Head examinations: Yes, 2/3 of the foetuses
Number of implants were recorded, if they were alive or dead (late vs early)
Statistics:
Body weight and foetal weight data were subjected to analysis of variance, using the Normal linear model for a one-way classification. Treatments were then compared using Dunnett’s t test.

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects: Yes

Details on maternal toxic effects: Slight reductions in maternal body weight gain and food consumption occurred at the 10% lipase dose level only

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects: Yes

Details on embryotoxic / teratogenic effects: At 5% and 10% lipase in the diet, there was a very slight reduction in foetal weight, together with some other evidence of slight immaturity amongst parameters of skeletal ossification state and in growth of the viscera of a small number of fetuses.

Effect levels (fetuses)

Key result
Dose descriptor:
NOAEL
Effect level:
other: >= 2% lipase by weight in the diet
Based on:
test mat.
Basis for effect level:
other: teratogenicity

Applicant's summary and conclusion

Conclusions:
Maternal effect of treatment in this study were slight reductions in weight gain and food consumption at 10% lipase in the diet.

At 5% and 10% lipase in the diet, there was a very slight reduction in foetal weight, together with some other evidence of slight immaturity amongst parameters of skeletal ossification state and in growth of the viscera of a small number of fetuses.

It was concluded that, under the conditions of this study, dose levels of 5% and 10% lipase by weight in the diet caused slight growth retardation of fetuses, while slight maternal toxicity was confined to the 10% lipase dose level.

No significant effect was considered to have occurred at a dose level of 2% lipase by weight in the diet. No teratogenic potential of lipase was demonstrated at any dose level up to 10% lipase by weight in the diet.
Executive summary:

Lipase, batch PPW 1798 was used for teratogenicity testing in rats.

 

Mated Sprague-Dawley rats were randomized into 3 treatment groups and one control group, each group containing 27 animals. These animals were exposed continuously to test diets from Day 6 to Day 17 of gestation, where Day 0 was the day of verification of mating by detection of a copulatory plug in situ. Dose levels applied were as follows:

 

 

% lipase by Weight in the Diet

Control

Low dose

Intermediate dose

High dose

 

0

2

5

10

 

It was concluded that, under the conditions of this study, dose levels of 5% and 10% lipase in the diet caused slight growth retardation of fetuses, while slight reductions in maternal body weight gain and food consumption occurred at the 10% lipase dose level only.

No significant effect was considered to have occurred at the 2% lipase level.

No teratogenic potential of lipase was demonstrated at any of the dose levels used.